Category: Regulatory/FDA

MMM: CME Video Addresses Conflict of Interest

MMM Features Kamp's Call for Industry Leadership on Off-label, Online Communications

OPDP to Industry: Voluntary Compliance Efforts in New Year Can Prevent Same Old Violations

MMM Previews Pharma Debates in DC: Prepare for a Wild Ride in 2012

Increased Funding for FDA Is a Result of Industry, Consumer Efforts

CMPI Hosting Panel to Discuss PDUFA Without Politics

FDA Approval Report Contains Good News for Patients and Industry

RPM Report: Pandora’s Box Officially Open as New Legal Challenges to FDA’s Off-label Restrictions Emerge

Par Pharma Case Asserts That First Amendment Protects Truthful Off-label Speech